I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Reeves, Brandi
74
results:
Search for persons
X
Format
Online (74)
Mediatypes
Articles (Online) (39)
OpenAccess-fulltext (35)
Sorted by: Relevance
Sorted by: Year
?
1
Daratumumab-based quadruplet therapy for transplant-eligibl..:
Callander, Natalie S.
;
Silbermann, Rebecca
;
Kaufman, Jonathan L.
...
Blood Cancer Journal. 14 (2024) 1 - p. , 2024
Link:
https://doi.org/10.1038/..
?
2
Blood cell JAKtivation aggravates cerebral venous thrombosi:
Reeves, Brandi
Blood Advances. 8 (2024) 12 - p. 3327-3329 , 2024
Link:
https://doi.org/10.1182/..
?
3
Daratumumab in transplant-eligible patients with newly diag..:
Chari, Ajai
;
Kaufman, Jonathan L.
;
Laubach, Jacob
...
Blood Cancer Journal. 14 (2024) 1 - p. , 2024
Link:
https://doi.org/10.1038/..
?
4
Health‐related quality of life in transplant‐eligible patie..:
Silbermann, Rebecca
;
Laubach, Jacob
;
Kaufman, Jonathan L.
...
American Journal of Hematology. 99 (2024) 7 - p. 1257-1268 , 2024
Link:
https://doi.org/10.1002/..
?
5
Post hoc analysis of daratumumab plus lenalidomide, bortezo..:
Nooka, Ajay K.
;
Kaufman, Jonathan L.
;
Rodriguez, Cesar
...
British Journal of Haematology. 204 (2024) 6 - p. 2227-2232 , 2024
Link:
https://doi.org/10.1111/..
?
6
Multivariable Analyses of Prognostic Factors for Progressio..:
Hassoun, Hani
;
Jacobus, Susanna J
;
Richardson, Paul G.
...
Transplantation and Cellular Therapy. 29 (2023) 2 - p. S396-S397 , 2023
Link:
https://doi.org/10.1016/..
?
7
HTRS2023.O8B.1 HIF-1 inhibition attenuates venous thrombosi..:
Reeves, Brandi
;
Ghosh, Shatadal
;
Moliterno, Alison
..
Research and Practice in Thrombosis and Haemostasis. 7 (2023) - p. 100214 , 2023
Link:
https://doi.org/10.1016/..
?
8
Stem Cell Mobilization Yields with Daratumumab- and Lenalid..:
Chhabra, Saurabh
;
Callander, Natalie
;
Watts, Nicole L.
...
Transplantation and Cellular Therapy. 29 (2023) 3 - p. 174.e1-174.e10 , 2023
Link:
https://doi.org/10.1016/..
?
9
POSTER: MPN-559 Bromodomain and Extra-terminal (BET) Inhibi..:
Watts, Justin
;
Hunter, Anthony
;
Iurlo, Alessandra
...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S196 , 2023
Link:
https://doi.org/10.1016/..
?
10
P1055: BROMODOMAIN AND EXTRA-TERMINAL (BET) INHIBITOR INCB0..:
Watts, Justin M.
;
Hunter, Anthony M.
;
Iurlo, Alessandra
...
HemaSphere. 7 (2023) S3 - p. e1792906 , 2023
Link:
https://doi.org/10.1097/..
?
11
P-164 Reduction in disease symptoms/impacts after daratumum..:
Silbermann, Rebecca
;
Laubach, Jacob
;
Kaufman, Jonathan
...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S125-S126 , 2023
Link:
https://doi.org/10.1016/..
?
12
MPN-559 Bromodomain and Extra-Terminal (BET) Inhibitor INCB..:
Watts, Justin
;
Hunter, Anthony
;
Iurlo, Alessandra
...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S403-S404 , 2023
Link:
https://doi.org/10.1016/..
?
13
A Plain Language Summary of Daratumumab Plus Lenalidomide/B..:
Nooka, Ajay K
;
Kaufman, Jonathan L
;
Rodriguez, Cesar
...
Future Oncology. 18 (2022) 40 - p. 4443-4456 , 2022
Link:
https://doi.org/10.2217/..
?
14
P-219: Daratumumab (DARA) + lenalidomide/bortezomib/dexamet..:
Nooka, Ajay
;
Kaufman, Jonathan
;
Rodriguez, Cesar
...
Clinical Lymphoma Myeloma and Leukemia. 22 (2022) - p. S155-S156 , 2022
Link:
https://doi.org/10.1016/..
?
15
Daratumumab plus lenalidomide, bortezomib and dexamethasone..:
Sborov, Douglas W.
;
Baljevic, Muhamed
;
Reeves, Brandi
...
British Journal of Haematology. 199 (2022) 3 - p. 355-365 , 2022
Link:
https://doi.org/10.1111/..
1-15